Revenue: As of FY2025, the actual value is USD 1.487 B, beating the estimate of USD 1.439 B.EPS: As of FY2025, the actual value is USD 0.68, beating the estimate of USD 0.5.EBIT: As of FY2025, the actual value is USD 45.5 M.<h3>Segment Revenue</h3><ul><li>Automotive: Revenue decreased by 11% to $737.9 million in fiscal year 2025 compared to $826.4 million in fiscal year 2024.</li><li>Medical: Revenue decreased by 7% to $396.2 million in fiscal year 2025 compared to $425.7 million in fiscal year 2024.</li><li>Industrial: Revenue decreased by 24% to $352.6 million in fiscal year 2025 compared to $462.4 million in fiscal year 2024.</li></ul><h3>Operational Metrics</h3><ul><li>Net Income: Decreased by 17% to $17.0 million in fiscal year 2025 from $20.5 million in fiscal year 2024.</li><li>Gross Profit: Decreased by 26% to $104.4 million in fiscal year 2025 from $140.3 million in fiscal year 2024.</li><li>Operating Income: Decreased by 8% to $45.5 million in fiscal year 2025 from $49.3 million in fiscal year 2024.</li><li>Operating Margin: Increased to 3.1% in fiscal year 2025 from 2.9% in fiscal year 2024.</li></ul><h3>Cash Flow</h3><ul><li>Operating Cash Flow: Increased significantly to $183.9 million in fiscal year 2025 from $73.2 million in fiscal year 2024.</li><li>Free Cash Flow: Not explicitly stated, but net cash used for investing activities was $14.7 million in fiscal year 2025 compared to $46.5 million in fiscal year 2024.</li></ul><h3>Unique Metrics</h3><ul><li>Restructuring Expense: Increased significantly to $11.0 million in fiscal year 2025 from $2.4 million in fiscal year 2024.</li><li>Gain on Disposal: Recorded a gain of $2.4 million from the sale of GES in fiscal year 2025.</li></ul><h3>Outlook / Guidance</h3><ul><li>The company expects consolidated net sales in fiscal year 2026 to decline marginally from fiscal year 2025, largely due to the continued impact of the loss of a major automotive program.</li><li>Moderate growth is expected in the medical market in fiscal year 2026.</li><li>The company plans to continue restructuring efforts, including the closure of the Tampa facility, with expected additional pre-tax restructuring charges between $0.5 million to $1.0 million.</li></ul>

Kimball Electron | 10-K: FY2025 Revenue Beats Estimate at USD 1.487 B